Full Press Release Details
Lexicon Pharmaceuticals Announces Preclinical Efficacy Data on Telotristat Ethyl's Antiproliferative Effects Against Various Cancer Cell Lines.
LXRX
Lexicon Pharmaceuticals Announces Preclinical Efficacy Data on Telotristat Ethyl's Antiproliferative Effects Against Various Cancer Cell Lines
Key Takeaway: Lexicon Pharmaceuticals Announces Preclinical Efficacy Data on Telotristat Ethyl's Antiproliferative Effects Against Various Cancer Cell Lines